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Abstract
Background: Spheroid cell structures (SCS) described in cell culture are used to study cell-cell and cell-matrix interactions. 
However, the role of the SCS in the repair process in vivo remains unexplored. The aim of the study was to examine the cellular 
composition of the spherical structures and their functional significance in the repair of the squamous epithelium in human papilloma 
virus-associated chronic cervicitis (HPV-CC). 
Methods and Results: The cytology and biopsy materials from 223 patients with HPV-CC were subjected to molecular testing for 
HPV DNA by Real-Time Polymerase Chain Reaction (Real-Time PCR) with genotyping and chromogenic in situ hybridization (CISH), 
as well as immunocytological and immunohistochemical analyses of p16INK4A, Ki67, SMA,  Vimentin,  CD34,  E-cadherin, Oct4,   
CD44, CKW markers. In the stem cell niche zone, these spheroid structures were discovered having proliferative activity and showing 
signs of producing stem cells involved in the repair of the cervical mucosa in HPV-CC. 
Conclusion: The persistence of the HPV in the stem cell niche zone cells in the cervix determines the chronization of inflammation 
in this area, with the ability to perform pathological repair. The immunophenotype of the spheroid cell structures in the HPV-CC includes 
cells with signs of stem cells (‘stemness’) and the mesenchymal-epithelial transition. 
Keywords: stem cell niche lesion; mesenchymal-epithelial transition; chronization of inflammation.
Introduction
The SCS over the recent years have captured the attention 
of  many  researchers.  More  than  2000  works  according  to 
PubMed 01.07.2013 have been focused on this problem. Vast 
majorities  of  studies  have  been  conducted  on  the  cultures  of 
non-transformed and cancer cells (3D culture models) and fetal 
tissues; a few studies were performed with animal experiments 
with the transfer of the SCS in the peritoneal cavity. However, the 
first mention of these multicellular spheroid structures was in the 
’80s of the previous century [1-3]. These cellular structures were 
described under various names, such as, reparative modules and 
epithelial-mesenchymal spheroids (EMSs) [4], micro-mass [5], 
mammosphere [6], and micro-tissue structures [7]. The spheroids 
were obtained by culturing the chondrocytes [8], hepatocytes [9], 
and tumor cells of various tissues [10-12].
According to E. Fennema et al. [13], the spheroid structures 
could be used to study the cell-cell and cell-matrix interactions, 
the properties of the progenitor and stem cells, as well as to 
create transplants. In addition, according to I. Saburina [4], the 
plasticity of the EMSs may serve as the donor of the epithelium 
for the stroma in the damaged areas.
  “Granulation  tissue”  described  by  R. Virchow  consists 
of  loops  of  the  newly  produced  capillary-type  blood  vessels 
and  mesenchymal  elements  forming  macroscopically  visible 
“granules”,  possibly  an  analog  of  the  cellular  spheroids  in 
the  tissue  culture.  However,  “the  spheroid  structures”  in 
the  granulation  tissue  are  composed  solely  of  mesenchymal 
derivatives.  We  observed  EMSs  formation  in  the  squamous 
epithelium, in the diseases of the cervix associated with HPV 
[14]. However, the question regarding their cellular composition 
and functional significance still remains open.
Material and Methods
A clinical-morphological and molecular-biological investi-
gation of the materials obtained from 223 women of reproductive 
age  with  chronic  cervicitis  associated  with  high-risk  types  of 
human  papilloma  virus  (HR-HPV)  was  performed.  Group  1 
consisted of 48 patients with HR-HPV and no other pathology 
of the cervix. Group 2 comprised 60 patients with HR-HPV-CC 
in combination with cervical intraepithelial neoplasia (CIN 1). 
Group 3 included 115 patients with HR-HPV-CC in combination 
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with CIN 2-3. The women ranged in age from 28 to 43 years. All 
the women were examined and treated at the Center in 2012. 
All the patients underwent molecular HPV DNA testing with 
genotyping of the virus, cytology testing (using the liquid-based 
cytology method) and cervical biopsy with immunocytological 
and immunohistochemical analyses of p16INK4A, Ki67.
The cervical samples were collected using an endocervical 
brush  and  placed  in  SurePath  medium.  The  cervical  samples 
were  used  for  liquid-based  cytology  and  DNA  testing  in  the 
Cobas  system  (Roche  Molecular  Systems,  USA).  The  Cobas 
system is a fully automated system that detects DNA on three 
separate channels: for HPV-16, HPV-18 and the pooled HPV of 
12 genotypes (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68).  
Liquid-based cytology was performed in the B&D TriPath 
system. The specimens were subjected to Papanicolaou staining. 
The results were evaluated based on the Bethesda classification 
(Wright TCJr, et al., 2006). In parallel, the same material was 
studied  using  immunocytochemistry  CINtec  PLUS  cytology 
kit  (Roche,  Germany)  to  detect  the  expression  of  p16INK4A 
and Ki67. Furthermore, we were trying to detecting the Oct4 
expression (MRQ-10, 1:100, Cell Marque, USA). 
The biopsy material was presented as cervical scrapings 
in  the  cases  of  CC  in  combination  with  CIN1,  and  with  the 
operating  pictures  (the  remote  cervix  cones)  in  the  cases  of 
CC  in  combination  with  CIN  2-3  to  study  HPV-CC  in  the 
surrounding intact cervical mucosa. Biopsies were fixed in 10% 
neutral formalin and embedded in paraffin. The serial paraffin 
sections  were  stained  with  hematoxylin  and  eosin  staining; 
the  immunohistochemical  detection  of  the  p16INK4A,  Ki67 
(Roche,  Germany),  SMA  (SP171,  1:50,  Springbioscience, 
USA),  Vimentin (SP20, 1:200,  Springbioscience, USA),  CD34 
(QBEnd/10, 1:100, Cell Marque, USA),  E-cadherin (EP700Y, 
RTU, Cell Marque, USA), Oct4 (MRQ-10, 1:100, Cell Marque, 
USA),  CD44 (DF1485, 1:50, Dako, Denmark),  CKWSS (1:500, 
Dako, Denmark), and p16INK4a (Е6Н4, CINtec histology kit, 
Roche, Germany) expression was performed using conventional 
methods. We used the Dako REAL EnVision Detection System 
(Dako,  Denmark)  kit  for  secondary  antibodies.  Positive  and 
negative control reactions were performed.
In  addition,  in  the  serial  paraffin  sections  (n=27),  we 
determined  the  localization  of  the  HR-HPV  DNA  (16,  18, 
31,  33,  and  35)  by  CISH  using    ZytoFast  PLUS  (Germany) 
kit.  Hybridization  was  performed  with  digoxigenin-labeled 
DNA probes. The hybridization results were visualized by the 
primary anti-digoxigenin antibodies, which were detected by the 
secondary antibodies. The reaction with diaminobenzidine led to 
the formation of the resistant brown-colored stain that was seen 
under the light microscope. Positive and negative controls were 
performed, which were represented by the histological slices of 
the cervix tested for the presence of HPV using Real-Time PCR. 
Results
 In the first phase, we evaluated the distribution of HR-
HPV  among  those  patients  with  HPV-CC  from  groups  1-3. 
Evidence of the HPV genotypes was found in these groups. For 
example, HPV-16 and HPV-18 were not found in the Group 1 
patients. All the 48(100%) patients were infected with the pooled 
HPV (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68). In Group 
2, the Cobas test revealed HPV-16 DNA in 12 (20%) women, 
whereas the combination of HPV-16 DNA with the other 12 types 
was determined in 48 (80%) women. In Group 3, the individual 
HPV-16 DNA was identified in 100 (87%) women, whereas the 
combination of the HPV-16 DNA with the other 12 types was 
identified in 15 (13%) women.
 In the second phase, the cytological diagnosis of CC was 
performed. In the cytology samples of Group 1 patients, we found 
koilocytes and signs of chronic inflammation as evidence of the 
reactive epithelial changes in combination with the symptoms of 
leukopedesis and the presence of inflammatory cells in the cytology 
samples  (lymphocytes,  macrophages,  eosinophils,  fibroblasts). 
In the groups with the HR-HPV-CC with CIN combination, a 
combination of these changes was observed with the presence 
of atypical squamous cells with dyskaryosis, hyperchromia and 
polymorphism of the nuclei with the formation of multicellular 
clusters in the samples. In the control group, only the cytologic 
signs of CC were recorded. In the immunocytochemical study, 
solitary proliferating Ki67- positive cells of the squamous and 
glandular epithelium, as well as solitary senescent cells expressing 
p16 were found in the HVP-CC patients. In the samples of HR-
HPV-CC women with CIN1, on double staining, atypical cells 
simultaneously expressing p16 and Ki67 markers were identified, 
which comprised from 15 to 100% of the squamous epithelium. 
We found multicellular clusters consisting of monomorphic cells 
with no signs of atypia, which expressed Ki67, Oct4 (Fig. 1a-b), 
an embryonic stem cell marker [19] and p16INK4A- negative 
cells in 5 cases of Group 1. 
In  the  third  phase,  we  conducted  histological  and 
immunohistochemical  studies  of  the  biopsy  and  surgical 
specimens [20-22].  The histological examination of the cervical 
mucosa from the HPV-CC women revealed a specific complex of 
morphological signs, such as lymphohistiocytic infiltration with 
some plasma cells, as well as the phenomenon of neo-angiogenesis 
in the lamina propria, leukopedesis of the lymphocytes, acanthosis 
and koilocytosis in the squamous epithelium.
In 56 cases from among the 223 (25%) HPV-CC patients, 
the  thickness  of  the  squamous  epithelium  revealed  epithelial-
mesenchymal SCS composed of the squamous cells of the basal 
and parabasal types with intact cell-cell contacts in the form of 
so-called bridges. Squamous cells with the CKWS expression in 
SCS had the preserved the intercellular contacts called “bridges” 
(Fig. 1c-d). In the center of several SCS, endothelium was present, 
located on the basal membrane. In addition, it was possible to see 
the formation of SCS in the zone of the stem cell niches around 
the  invaginated  blood  capillaries.  On  double  staining  of  the 
p16INK4A and Ki67 in the SCS described, only the expression 
of Ki67 was detected in some epithelial and endothelial cells. In 
Fig. 1(a). 
SCS in liquid-based cytology sample. 
Stained by Papanicolaou (x 1000)
Fig. 1(b). 
Oct4+ cells in the liquid-based 
cytology samples.
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the HPV-CC patients, the p16INK4A oncomarker was absent in 
the SCS cells. Some SCS contained koilocytes and cells with 
apoptotic  changes  (Fig.  1e-f).  Formations  such  as  SCS  were 
found, although in the CIN area they differed morphologically, 
and expressed the Ki67 and r16INK4A oncomarkers on double 
staining. 
In the fourth phase, we studied the immunophenotype of 
the  SCS  in  the  squamous  epithelium  of  those  with  HPV-CC. 
The SCS are clearly visible in the CC areas, due to the greater 
expression of Oct4, CD34-, CD44-, and E-cadherin compared 
with  the  adjacent  epithelium  (Fig.  1d-e;  Fig.  2). Thus,  many 
SCS were localized in the cervical transformation zone, which 
is the stem cell niche, located directly on the basal membrane. 
Oct4 was detected as a brown-colored staining of the nuclei and 
cytoplasm of the cells, located around the perimeter of the SCS or 
at one of its poles, as well as in certain endothelial cells adjacent 
to the SCS, and in the connective tissue cells (Fig. 2a-b). The 
expression of CD34 was observed in the endothelium of the SCS 
capillaries; the reaction product was localized in the endothelial 
cell cytoplasm in the center of the SCS or in the invaginated 
blood capillaries close to the basal membrane. 
Besides,  CD44  and  E-cadherin  were  found  in  the  cells 
of the squamous epithelium of the SCS (Fig. 2c). In this case, 
the  intercellular  bridges  (desmosomal  contacts)  were  clearly 
contoured.  Mainly,  Vimentin  was  detected  in  the  capillary 
cells (Fig. 2d); however, Oct4 was found in the cytoplasm and 
nuclei of some epithelial cells in the SCS as well. The question 
regarding their origin in the SCS in the squamous epithelium 
is still not answered, but is probably due to the phenomenon 
of mesenchymal-epithelial transition (MET) in the SCS of the 
cervical squamous epithelium, as we discovered. Thus, the SCSs 
contained the cells with the epithelial immunophenotype (СК 
WSS+ и E-cadherin+), with the mesenchymal immunophenotype 
(Vimentin+,  SMA+,  СК  WSS-,  and  E-cadherin-)  and  the 
epithelial-mesenchymal  phenotype  (Vimentin+,  SMA+,  СК 
WSS+, and E-cadherin+).  
In the fifth phase, we investigated the localization of HR-
HPV DNA (16, 18, 31, 33, and 35) using CISH in the сervical 
biopsies of patients with СС. Viral DNA was detected in the 
nuclei of the parabasal and basal epithelial cells, koilocytes, as 
well as in the capillary endothelium, fibroblastic cells and cells of 
the inflammatory infiltrate (Fig. 2e-f). 
Discussion
 In the HPV genotyping test we found that the characteristic 
of  the  HPV-CC  without  CIN  is  the  absence  of  HPV-16.  In 
contrast,  the  combination  of  the  HPV-CC  with  CIN  1-3  was 
characterized  by  HPV-16  presence,  both  individually  and  in 
combination with the other HR-HPV DNA genotypes. Similar 
results have been described by several authors [15-17]. The HPV-
18 was not detected, which is consistent with the published data 
on its active participation in the occurrence of hysterocarcinoma 
[18]. It should be noted that the HPV DNA was detected in the 
zone of the stem cell niche, where an infection was present not 
only in the epithelial cells, including SCS, but in the vascular 
endothelium in the MET areas as well. Thus, it can be assumed 
that HPV is involved in MET. This assumption is also confirmed 
by  the  literature.  In  the  experiments,  in  the  HPV16  E6/E7 
Fig. 1(c). 
SCS with koilocytes and  the capillary 
in centre. Stained with H&E (x 600)
Fig. 1(d). 
SCS with proliferation of the Ki67+ 
cells and the Р16INKA4- cells. 
Immunohistochemical staining (x 600)
Fig. 1(e).
E-cadherin+ cells in SCS. 
Immunohistochemical staining (x 600)
Fig. 1(f). 
СD 34+ cells in SCS. 
Immunohistochemical staining (x 600)
Fig. 2(a). 
Oct4+ cells in SCS. 
Immunohistochemical staining (x 600)
Fig. 2(b). 
Oct4+ cells in SCS in the zone of 
the stem cell niche of the cervix.
Immunohistochemical staining (x 600)
Fig. 2(c). 
СD 44+ cells in SCS.
Imunohistochemical staining (x 600)
Fig. 2(d). 
Vimentin+ cells in SCS. 
Immunohistochemical staining (x 600)
Fig. 2(e). 
DNA HPV in the forming SMS. 
CISH (x 100)
Fig. 2(f). 
DNA HPV in the squamous epithelium 
and the capillary endothelium in 
the zone of the stem cell niche of the 
cervix. CISH (x 1000).195                           E. A. Kogan et al. / International Journal of BioMedicine 3(3) (2013) 192-196
infected cell culture, HPV was revealed to induce the phenotypic 
and molecular programming of the MET in the culture of normal 
keratinocytes. The fibroblast growth factor was found to inhibit 
the expression of the epithelial marker E-cadherin and increase 
the expression of Vimentin, the mesenchymal marker [24-25].  In 
cervical cancer, Lee et al., also observed MET programming [26]. 
Therefore, the spheroid structures represented by the cell 
clones having signs of stem cells and functioning as the reparative 
formations in the HPV-CC patients, contained HR-HPV types 
that, probably, can potentiate MET.
The spheroidal structures discovered by us in the HPV-CC 
were composed of cells with proliferative activity and signs of 
‘stemness’. Considering the proliferative activity of the SCS, the 
cellular structure and the lack of p16INK4A expression lead us 
to suggest that these structures are involved in the repair of the 
cervical mucosa in HPV-CC. The composition of the reparative 
SCS in HPV-CC includes those cells with the expression of the 
stem cells markers, which are involved in squamous epithelium 
repair. 
The  phenomenon  of  epithelial-mesenchymal  transition 
(EMT) has been described in the earlier studies on tissue culture 
and in vivo during the invasion and metastasis of the malignant 
tumors. MET is the reverse process of EMT, which is discussed in 
some chronic inflammatory diseases [23]. Our data and literature 
data confirm the existence of MET in HPV-CC and enables one 
to assume that the cells with signs of ‘stemness’ in the SCS may 
be a result of the MET, possibly, with the participation of the 
tissue stem cells and, also possibly with bone marrow-originated 
mesenchymal stem cells.
Findings:
1. The persistence of the HPV in the cells of the stem cell 
niche zone of the cervix causes the chronization of inflammation 
here, having the capacity for pathological repair.
2. Regarding the repair of the cervical mucosa in HPV-CC, 
we  found  the  participation  of  special  epithelial-mesenchymal 
SCSs, which had been formed in the zone of the stem cell niche 
and were able to accomplish the proliferative activity.
3. The cells of the spheroid structures in the HPV-CC are 
of the heterogeneous immunophenotype and include cells with 
the signs of stem cells and the mesenchymal-epithelial transition 
which, in turn, suggests the possibility of MET in the repair of 
epithelium in the HPV-CC.
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